Immune suppressive microenvironment in liver metastases contributes to organ-specific response of immunotherapy in advanced non-small cell lung cancer

BACKGROUND: The liver is a frequent site of metastases and liver metastases (LM) correlate with diminished immunotherapy efficacy in non-small cell lung cancer (NSCLC). This study aimed to analyze whether tumor response to immunotherapy differs between pulmonary lesions (PL) and LM in NSCLC and to e...

Descripción completa

Detalles Bibliográficos
Autores principales: Deng, Jia-Yi, Gou, Qing, Yang, Lingling, Chen, Zhi-Hong, Yang, Ming-Yi, Yang, Xiao-Rong, Yan, Hong-Hong, Wei, Xue-Wu, Liu, Jia-Qi, Su, Jian, Zhong, Wen-Zhao, Xu, Chong-Rui, Wu, Yi-Long, Zhou, Qing
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2023
Materias:
Clinical/Translational Cancer Immunotherapy
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10357800/
https://www.ncbi.nlm.nih.gov/pubmed/37463790
http://dx.doi.org/10.1136/jitc-2023-007218

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10357800/
https://www.ncbi.nlm.nih.gov/pubmed/37463790
http://dx.doi.org/10.1136/jitc-2023-007218

Ejemplares similares